// App-Quantinova.ai

6029 : Comparison between lobaplatin and cisplatin plus 5-fluorouracil combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicenter randomized phase III clinical trial.

Researchers

Presenter

  • Kuiyuan Liu

Principal Investigators

  • Wen-Ze Qiu

  • Ya-Hui Yu

  • Guo-Ying Liu

  • Hu Liang

  • Wang-Zhong Li

  • Shu-Hui Lv

  • Liang-Ru Ke

  • Hao-Yuan Mo

  • Guo Ling

  • Ming-Yuan Chen

  • Ka-Jia Cao

  • Chong Zhao

  • Chao-Nan Qian

  • Xing Lv

  • Xiang Yanqun

  • Xiang Guo

  • Xin-Jun Huang

Medical Centers

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  • Cancer Center Sun Yat Sen University, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adrucil injection

  • lobaplatin

  • Cisplatin

Outcome

  • N/A


Study Design

  • Randomized

  • Multicenteric

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final